FQ
ALIM

First Quadrant’s Alimera Sciences ALIM Stock Holding History

First Quadrant’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-600
Closed -$34K – 824
2013
Q3 		$34K Buy
600
+300
+100% +$18.8K ﹤0.01% 712
2013
Q2 		$22K Buy
+300
New +$17.3K ﹤0.01% 733

Other funds holding ALIM

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Quadrant's ALIM Position: Q4 2013 in Review

First Quadrant sold out of Alimera Sciences (ALIM) in Q4 2013, closing a stake of 600 shares — an estimated $34K sold.

First Quadrant first reported a position in ALIM in Q2 2013 and held it in 2 quarters. The position peaked at $34K in Q3 2013. 44 funds tracked by Wall St. Rank hold ALIM as of Q4 2013.

  • First Quadrant reported no remaining Alimera Sciences position as of Q4 2013 after selling out during the quarter.
  • First Quadrant sold 600 Alimera Sciences shares in Q4 2013, an estimated $34K.
  • First Quadrant first reported a position in Alimera Sciences in Q2 2013 and held it in 2 quarters.
  • First Quadrant's Alimera Sciences position peaked at $34K in Q3 2013.
  • 44 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2013.

Based on First Quadrant's 13F filing for Q4 2013, filed 29 Jan 2014.